美国,Biosearch Technologies,  
Biosearch Technologies是专业性荧光定量PCR探针合成及标记服务公司，提供与世界上各种荧光定量PCR仪配套的探标记方式及荧光素。

Biosearch Technologies的根源可以追溯到1978年，现任总裁兼首席执行官罗恩 - 库克，博士创立了“Biosearch”，为新兴的生物技术产业提供研究工具。在20世纪80年代，Biosearch自主研发固相DNA合成器，如SAM I, the Cyclone, Biosearch 8700 and Biosearch 8800 Prep。这些生产制造的寡核苷酸的技术，催生新寡核苷酸技术的发展。最引人注目的是1982年，Kary Mullis在Cetus 公司使用了BiosearchSAM I合成DNA创造使用的寡核苷酸，其最终导致的聚合酶链反应（PCR）的发现。





Biosearch Technologies commits itself to perfecting the design and manufacture of innovative nucleic acid based products that accelerate the discovery and application of genomic information. We strive for the highest levels of product quality and customer satisfaction in the diverse markets to which we cater worldwide.

Quality Reagents for Quality Science
Product quality is of utmost importance to us. At Biosearch, we are acutely aware of the time, effort and money our customers invest in their work. Poor quality reagents can ruin even the best-designed experiments. Our commitment to quality is a direct result of this awareness. From the receiving dock to the shipping dock to your lab bench, we have developed exhaustive quality assurance protocols that test and document each important physical parameter of every compound that enters and leaves our labs. Starting with the basic raw materials and ending with the final highly-purified end product, we maintain purity and quality documentation that ships with every product we sell.